GA and ADM (Adriamycin) exert a potent anti‐tumor effect on the A549 xenograft model by inhibiting P‐glycoprotein and NF‐κB, attenuating ADM‐induced cardiotoxicity, and sensitizing lung cancer cells to ADM.191. This evidence concerns the gene NFKB1 and neoplasm.